Ketamine Treatment Plans for Chronic Conditions

Part of paid clinical trials in Helena, Montana.

Sponsor
RIVER Foundation
Study ID
NCT06038409
Status
Recruiting
Apply to this trial

Conditions

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Ketamine — DRUG
    The efficacy of the various approaches to prescribing Ketamine currently in use off-label. The focus will be to include ketamine within the treatment plan of those with chronic conditions

Study Details

A study aimed to assess the efficacy of the various approaches to prescribing Ketamine currently in use off-label. The focus will be to include ketamine within the study plan of those with chronic conditions who are receiving ketamine.

Key Dates

Start date
Jan 1, 2023
Status verified
Jan 2024
Primary completion
Jan 1, 2029
Completion
Jun 1, 2029

Study Design

Enrollment
500 participants (estimated)

Arms

  • Arm: Chronic Pain
    The use of ketamine in chronic pain
  • Arm: Depressive Disorders
    The use of ketamine in depressive disorders
  • Arm: Anxiety Disorders
    The use of ketamine in anxiety disorders
  • Arm: Chronic Condtions
    The use of ketamine in chronic conditions

Primary Outcome Measure

Ketamine route of use acceptability. [ Time Frame: through study completion, an average of 1 year ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
RIVER TelehealthHelenaMontana59601
Ed Lesofski, MS
[email protected]
406-465-9504
James Taggart, MD
Frank Yurasek, PhD
Edward Lesofski, MS
Jeffery Newton

Find similar trials in Helena, MT

By condition
Depression
By specialty
PsychiatryMental healthBehavioral health
By research site
RIVER Telehealth· Helena, MT

Related Studies